Molecular Health GmbH
69115 Heidelberg, Baden-Württemberg
Christian Meisel, Chief Medical Officer
Company main phone:
+49 (6221) 438510 Website: www.molecularhealth.com
|Source of foundation:||Independent foundation|
Corporate description / mission:
Molecular Health is a biomedical company that is transforming molecular data and medical knowledge into actionable clinical information for more efficient and safe targeted therapies for each individual patient. The company generates individualized analysis and clinical interpretation for evidence-based targeted therapy identification utilizing published medical knowledge in a clinical context. In Europe, the company has the first registered medical device of its kind for personalized cancer medicine.
State of ownership: Private / independent
- Artificial intelligence (AI)
- Medical Big Data & analytics
- Large biotech & big pharma
- Small biotech
Summary Products / Services / Technologies
Description of products:
MH Predict is an application designed to predict clinical trial success using the latest developments in Artificial Intelligence (AI) and Machine Learning (ML).
MH Mendel supports human geneticists to identify clinically significant genetic variants and create a diagnostic report for individual patients.
Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants associated with hereditary breast and ovarian cancer (HBOC) syndrome from NGS-based assessment of BRCA1 and BRCA2 and other HBOC related genes.